[1]
2025. A multicenter, prospective, randomized controlled modified multi-platform (matriarch) trial evaluating several cellular, acellular, and matrix-like products (CAMPs) and standard of care versus standard of care alone in the management of non-healing diabetic foot and venous leg ulcers (STABLECAMP). International Journal of Tissue Repair. 1, 1 (Nov. 2025). DOI:https://doi.org/10.63676/3csvta73.